The increasingly sophisticated and accurate definition of evidence-based scientific recommendations in the clinical management of hereditary breast cancer might provide in the future a progressively specialized approach, also to rare genetic clinical entities, such as hereditary lobular breast cancer, a novel inherited cancer predisposition linked to germline CDH1 mutation, currently object of extensive and significant research [96]. This evidence concerns the gene CDH1 and Hereditary breast cancer.